Immunic Inc [NASDAQ: IMUX] price plunged by -25.28 percent to reach at -$0.23.
The one-year IMUX stock forecast points to a potential upside of 94.58. The average equity rating for IMUX stock is currently 1.00, trading closer to a bullish pattern in the stock market.
Guru’s Opinion on Immunic Inc [IMUX]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for IMUX shares is $12.54 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on IMUX stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
William Blair have made an estimate for Immunic Inc shares, keeping their opinion on the stock as Outperform, with their previous recommendation back on March 25, 2025. While these analysts kept the previous recommendation, H.C. Wainwright raised their target price to Buy. The new note on the price target was released on November 25, 2024, representing the official price target for Immunic Inc stock. Previously, the target price had yet another raise to $5, while Leerink Partners analysts kept a Outperform rating on IMUX stock.
IMUX Stock Performance Analysis:
Immunic Inc [IMUX] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -26.08. With this latest performance, IMUX shares dropped by -46.87% in over the last four-week period, additionally sinking by -38.17% over the last 6 months – not to mention a drop of -45.59% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for IMUX stock in for the last two-week period is set at 27.35, with the RSI for the last a single of trading hit 18.88, and the three-weeks RSI is set at 32.86 for Immunic Inc [IMUX]. The present Moving Average for the last 50 days of trading for this stock 1.0305, while it was recorded at 0.8637 for the last single week of trading, and 1.1948 for the last 200 days.
Insight into Immunic Inc Fundamentals:
Immunic Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 0.74 and a Current Ratio set at 0.74.
Immunic Inc [IMUX] Institutonal Ownership Details
The top three institutional holders of IMUX stocks are: BVF INC/IL with ownership of 8.9 million shares, which is approximately 9.15%. AVIDITY PARTNERS MANAGEMENT LP, holding 8.9 million shares of the stock with an approximate value of $$9.88 million in IMUX stocks shares; and AVIDITY PARTNERS MANAGEMENT LP, currently with $$8.1 million in IMUX stock with ownership which is approximately 7.4954%.
